Topic: contract manufacturer
Betting heavily on a less-regulated CMO market, a Chinese company intends to build a massive biologics plant over the next several years.
China CDMO WuXi Biologics has picked Ireland for its first biologics plant outside of China, a facility in which it will invest €325 million.
Thermo Fisher features its employees and the patients they help in a new campaign that personalizes its drug development and delivery services.
Washington-based CDMO AGC Biologics said it will expand its headquarters and manufacturing capacity.
Two European manufacturing plants discarded by Big Pharma have been bought by Asian companies and reopened.
Samsung is tamping down investor excitement about a fourth biologics manufacturing site after one of its execs suggested it could be built sooner.
WuXi's small molecule CDMO STA is adding a drug development services operation as it builds itself into an end-to-end CDMO.
Australia’s TPI Enterprises has struck a deal to buy the opioid and CMO tablet businesses of Norway’s Vistin Pharma.
Gilead hit with revived lawsuit claiming it sourced a key HIV drug ingredient from an unapproved Chinese manufacturer.
BASF will expand its ibuprofen API capacity with a new plant in Ludwigshafen, Germany, and expansion of a facility in Texas.